What is it about?
The name Patrick Serruys is synonymous with stenting and interventional cardiology, which he has been involved with since its inception. He talks us through the evolution of stents from the early days and outlines what needs to happen to improve the current generation of bioresorbable scaffolds.
Photo by Brooke Lark on Unsplash
Why is it important?
Serruys was the first-ever chair of interventional cardiology at the Erasmus Medical Centre (EMC) in the Netherlands and is currently Professor of Cardiology at the National Heart and Lung Institute (NHLI) of Imperial College, in London, UK. He pioneered quantitative angiography over 25 years ago at EMC and subsequently became involved in the development of drug-eluting stents with Eduardo Souza MD. Dissatisfied with the notion of implanting a ‘metal cage’ into a living organism, he pursued the concept of a more organic alternative and focused on bioresorbable scaffolds.
Read the Original
This page is a summary of: The Evolution of Bioresorbable Scaffolds, European Heart Journal, May 2017, Oxford University Press (OUP), DOI: 10.1093/eurheartj/ehy389.
You can read the full text:
The following have contributed to this page